Cegedim SA (LON:0DYQ)
10.55
0.00 (0.00%)
At close: Oct 15, 2025
Cegedim Revenue
Cegedim had revenue of 322.5 million EUR in the half year ending June 30, 2025, with 7.14% growth. This brings the company's revenue in the last twelve months to 658 million, up 3.79% year-over-year. In the year 2024, Cegedim had annual revenue of 654.5 million with 6.25% growth.
Revenue (ttm)
658.00M EUR
Revenue Growth
+3.79%
P/S Ratio
0.23
Revenue / Employee
98.81K EUR
Employees
6,659
Market Cap
129.48M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 654.50M | 38.50M | 6.25% |
Dec 31, 2023 | 616.00M | 60.79M | 10.95% |
Dec 31, 2022 | 555.21M | 30.50M | 5.81% |
Dec 31, 2021 | 524.71M | 27.77M | 5.59% |
Dec 31, 2020 | 496.94M | -6.81M | -1.35% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
GSK plc | 31.63B |
Haleon | 11.02B |
Smith & Nephew | 4.33B |
Hikma Pharmaceuticals | 2.35B |
ConvaTec Group | 1.72B |
Spire Healthcare Group | 1.55B |
Genus | 672.80M |
Cegedim News
- 24 days ago - Cegedim's profitability improving as expected in H1 2025 - Benzinga